GLP-1 Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: native GLP-1 infusion physiology

Metabolic Research peptide Lyophilized verified

Also known as: Glucagon-like peptide-1

Quick Facts

Reference Sizes
1 mg, 5 mg
Calculator
Preset available
Storage
Use source-label storage wording. Track lot, storage location, and open/reconstitution date.
Solubility
Research formulation dependent

Catalog Description

GLP-1 (glucagon-like peptide-1) is the native incretin hormone secreted by intestinal L-cells in response to food intake, stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and acting centrally on satiety pathways. Its native half-life is only about 2 minutes due to rapid DPP-4 enzymatic degradation - this extreme instability is precisely why every approved and investigational 'GLP-1 drug' in this catalog (semaglutide, tirzepatide, liraglutide, exenatide, retatrutide, etc.) is a chemically modified analog engineered for DPP-4 resistance and extended half-life, rather than native GLP-1 itself. Native GLP-1 has essentially no standalone therapeutic research use given this instability; its primary catalog relevance is as the physiological reference point for understanding why the analog compounds are designed the way they are.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
Approximately 1.5-5 minutes in plasma because of rapid DPP-4 degradation
Onset
Metabolic effects occur during continuous infusion
Administration Routes (Research)
IV in native-peptide human physiology studiesLaboratory use

Reported Research Effects

Reported Research Side Effects

Data source: Primary human continuous-infusion study and native-peptide pharmacology

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

Research Interactions

Flagged Avoid / Caution Combinations (Research)

Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.

Research Notes

Native GLP-1 is not interchangeable with marketed long-acting GLP-1 receptor agonists. Its minute-scale half-life generally requires continuous infusion in human studies.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

Native GLP-1 continuous-infusion trial — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/11473079/
Native GLP-1 short plasma half-life — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/12039708/

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Articles

Published articles on this site that mention GLP-1 or one of its catalog aliases.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top